193 related articles for article (PubMed ID: 6883944)
1. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
Guay DR; Matzke GR; Bockbrader HN; Dancik J
Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
[TBL] [Abstract][Full Text] [Related]
2. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
[TBL] [Abstract][Full Text] [Related]
3. Prediction of cimetidine disposition in the aged.
Ritschel WA
Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
[TBL] [Abstract][Full Text] [Related]
5. Impact of cimetidine on the pharmacokinetics of theophylline.
Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cimetidine in patients with liver disease.
González-Martin G; Arancibia A; Fajuri M; Chesta J; Novoa X
Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163
[TBL] [Abstract][Full Text] [Related]
7. Cimetidine pharmacokinetics after oral administration of cimetidine retard in normal and impaired renal function.
Shaheen RA; Zazgornik J; Kuska J; Kokot F; Schneider J
Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):480-6. PubMed ID: 2272709
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of cimetidine in man.
Walkenstein SS; Dubb JW; Randolph WC; Westlake WJ; Stote RM; Intoccia AP
Gastroenterology; 1978 Feb; 74(2 Pt 2):360-5. PubMed ID: 620910
[TBL] [Abstract][Full Text] [Related]
9. [Cimetidine pharmacokinetics].
Katrukha SP; Karpenko EV; Davydov SM; Blinkov IL; Kukes VG
Farmakol Toksikol; 1986; 49(5):36-40. PubMed ID: 3770173
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
Somogyi A; Rohner HG; Gugler R
Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F
Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684
[TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine on the absorption and efficacy of orally administered furosemide.
Rogers HJ; Morrison P; House FR; Bradbrook ID
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):8-11. PubMed ID: 7056605
[TBL] [Abstract][Full Text] [Related]
14. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
15. Cimetidine disposition in obesity.
Abernethy DR; Greenblatt DJ; Matlis R; Gugler R
Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798
[TBL] [Abstract][Full Text] [Related]
16. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
Abernethy DR; Greenblatt DJ; Shader RI
J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
[TBL] [Abstract][Full Text] [Related]
17. Effects of renal failure on blood levels of cimetidine.
Ma KW; Brown DC; Masler DS; Silvis SE
Gastroenterology; 1978 Feb; 74(2 Pt 2):473-7. PubMed ID: 620915
[TBL] [Abstract][Full Text] [Related]
18. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
Bjaeldager PA; Jensen JB; Nielsen LP; Larsen NE; Hvidberg EF
Nephron; 1983; 34(3):159-63. PubMed ID: 6877447
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
Bodemar G; Norlander B; Walan A
Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
